P C Evans

890 total citations
18 papers, 697 citations indexed

About

P C Evans is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P C Evans has authored 18 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P C Evans's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Birth, Development, and Health (5 papers). P C Evans is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Birth, Development, and Health (5 papers). P C Evans collaborates with scholars based in New Zealand and United States. P C Evans's co-authors include Jane E. Harding, Peter D. Gluckman, Mark H. Oliver, Bernhard H. Breier, P. D. Gluckman, N. S. Bassett, Sonja Woodall, James W. Paxton, Peter Gluckman and Bruce C. Baguley and has published in prestigious journals such as Analytical Biochemistry, Endocrinology and American Journal of Obstetrics and Gynecology.

In The Last Decade

P C Evans

18 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P C Evans New Zealand	11	489	358	213	102	84	18	697
H. P. Zahradnik Germany	19	185 0.4×	245 0.7×	81 0.4×	96 0.9×	115 1.4×	58	875
Michael E. Toaff United States	14	106 0.2×	359 1.0×	204 1.0×	122 1.2×	183 2.2×	31	945
William J. Dignam United States	14	167 0.3×	129 0.4×	183 0.9×	85 0.8×	76 0.9×	33	582
Nicole K. MacLennan United States	12	492 1.0×	260 0.7×	50 0.2×	339 3.3×	74 0.9×	13	828
J Schwers Belgium	10	110 0.2×	93 0.3×	95 0.4×	95 0.9×	212 2.5×	31	485
Scott W. Walsh United States	9	261 0.5×	317 0.9×	32 0.2×	34 0.3×	28 0.3×	9	484
P. López-Luna Spain	10	182 0.4×	122 0.3×	65 0.3×	64 0.6×	27 0.3×	19	456
R. Poisner United States	10	86 0.2×	129 0.4×	66 0.3×	53 0.5×	13 0.2×	15	318
E. J. Plotz United States	14	73 0.1×	50 0.1×	112 0.5×	53 0.5×	102 1.2×	38	582
Cinzia L. Paolini Italy	13	513 1.0×	422 1.2×	47 0.2×	77 0.8×	46 0.5×	16	657

Countries citing papers authored by P C Evans

Since Specialization

Citations

This map shows the geographic impact of P C Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P C Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P C Evans more than expected).

Fields of papers citing papers by P C Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P C Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P C Evans. The network helps show where P C Evans may publish in the future.

Co-authorship network of co-authors of P C Evans

This figure shows the co-authorship network connecting the top 25 collaborators of P C Evans. A scholar is included among the top collaborators of P C Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P C Evans. P C Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Harding, Jane E., N. S. Bassett, Bernhard H. Breier, et al.. (1998). Fetal growth and placental function. Molecular and Cellular Endocrinology. 140(1-2). 115–120. 160 indexed citations

Harding, Jane E., P C Evans, & Peter D. Gluckman. (1997). Maternal Growth Hormone Treatment Increases Placental Diffusion Capacity But Not Fetal or Placental Growth in Sheep*. Endocrinology. 138(12). 5352–5358. 57 indexed citations

Harding, Jane E., P C Evans, & Peter D. Gluckman. (1996). Maternal growth hormone treatment increases placental diffusion capacity but not fetal or placental growth in sheep. Placenta. 17(5-6). A15–A15. 3 indexed citations

Oliver, Mark H., Jane E. Harding, Bernhard H. Breier, et al.. (1995). The effects of ovine placental lactogen infusion on metabolites, insulin-like growth factors and binding proteins in the fetal sheep. Journal of Endocrinology. 144(2). 333–338. 21 indexed citations

Harding, Jane E., et al.. (1994). Insulin-like growth factor 1 alters feto-placental protein and carbohydrate metabolism in fetal sheep.. Endocrinology. 134(3). 1509–1514. 94 indexed citations

Harding, Jane E., et al.. (1994). Maternal insulin-like growth factor-I infusion alters feto-placental carbohydrate and protein metabolism in pregnant sheep.. Endocrinology. 135(3). 895–900. 66 indexed citations

Oliver, Mark H., Jane E. Harding, Bernhard H. Breier, P C Evans, & Peter D. Gluckman. (1993). Glucose but Not a Mixed Amino Acid Infusion Regulates Plasma Insulin-Like Growth Factor-I Concentrations in Fetal Sheep. Pediatric Research. 34(1). 62–65. 124 indexed citations

Evans, P C, et al.. (1993). A Colorimetric Assay for Amino Nitrogen in Small Volumes of Blood: Reaction with β-Naphthoquinone Sulfonate. Analytical Biochemistry. 208(2). 334–337. 27 indexed citations

Harding, Jane E., Valerie Charlton, & P C Evans. (1992). Effects of ß-hydroxybutyrate infusion on hind limbmetabolism in fetal sheep. American Journal of Obstetrics and Gynecology. 166(2). 671–676. 4 indexed citations

10.

Oliver, Mark H., Jane E. Harding, Bernhard H. Breier, P C Evans, & Peter D. Gluckman. (1992). The Nutritional Regulation of Circulating Placental Lactogen in Fetal Sheep. Pediatric Research. 31(5). 520–523. 23 indexed citations

11.

Harding, Jane E., et al.. (1992). Intrauterine feeding of the growth retarded fetus: can we help?. Early Human Development. 29(1-3). 193–197. 46 indexed citations

12.

Young, Deborah, P C Evans, & James W. Paxton. (1990). Quantitation of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 528(2). 385–394. 9 indexed citations

13.

Kestell, P., James W. Paxton, P C Evans, et al.. (1990). Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.. PubMed. 50(3). 503–8. 26 indexed citations

14.

Paxton, James W., P C Evans, & Janet Hardy. (1989). The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino) phenylamino]-4-acridinecarboxamide (CI-921) in the rabbit. Cancer Chemotherapy and Pharmacology. 23(5). 291–295. 4 indexed citations

15.

Kestell, P., et al.. (1988). THIOLYTIC CLEAVAGE AND BINDING OF THE ANTITUMOUR AGENT CI-921 IN BLOOD. Drug metabolism and drug interactions. 6(3-4). 327–336. 4 indexed citations

16.

Paxton, James W., Janet Hardy, P C Evans, V.J. Harvey, & Bruce C. Baguley. (1988). The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in a phase 1 trial. Cancer Chemotherapy and Pharmacology. 22(3). 235–240. 3 indexed citations

17.

Hardy, Janet, VJ Harvey, James W. Paxton, et al.. (1988). Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).. PubMed. 48(22). 6593–6. 23 indexed citations

18.

Paxton, James W., et al.. (1987). Dose-dependent pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4-acridinecarboxamide (CI-921) in rabbits. Cancer Chemotherapy and Pharmacology. 20(1). 13–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact